A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
N/A
This study will collect biospecimens (including blood, tissue, and stool sa...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2022-09-30
Trial ID
NCT05568420
Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PHASE1
Cure rates for patients with high grade glioma remain disappointing, in par...
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
PHASE3
This phase III trial compares 6 months of human epidermal growth factor rec...